Dosing & Reconstitution Guide Educational guide for reconstitution and daily dosing Standard / Gradual Approach (3 mL = ~33.3 mg/mL) Frequency: Inject once daily subcutaneously, 5 days per week (MonFri) with weekends off [5]
Most patients who respond well continue treatment for at least 12 months or longer
Its long half-life and stable once-weekly profile make it practical for chronic metabolic research protocols
Hsieh P-H, Huang J-Y, Nfor ON, Lung C-C, Ho C-C, Liaw Y-P
Genes with counts below a threshold of 20 were excluded from subsequent analysis
La sua popolarit deriva dalla capacit di combinare due recettori incretinici GIP e GLP-1 in ununica molecola, una caratteristica che rappresenta unevoluzione importante rispetto ai classici agonisti GLP-1